Literature DB >> 24468637

A proposed fractional-order Gompertz model and its application to tumour growth data.

Larisse Bolton1, Alain H J J Cloot2, Schalk W Schoombie2, Jacobus P Slabbert3.   

Abstract

A fractional-order Gompertz model of orders between 0 and 2 is proposed. The main purpose of this investigation is to determine whether the ordinary or proposed fractional Gompertz model would best fit our experimental dataset. The solutions for the proposed model are obtained using fundamental concepts from fractional calculus. The closed-form equations of both the proposed model and the ordinary Gompertz model are calibrated using an experimental dataset containing tumour growth volumes of a Rhabdomyosarcoma tumour in a mouse. With regard to the proposed model, the order, within the interval mentioned, that resulted in the best fit to the data was used in a further investigation into the prediction capability of the model. This was compared to the prediction capability of the ordinary Gompertz model. The result of the investigation was that a fractional-order Gompertz model of order 0.68 produced a better fit to our experimental dataset than the well-known ordinary Gompertz model.
© The Authors 2014. Published by Oxford University Press on behalf of the Institute of Mathematics and its Applications. All rights reserved.

Entities:  

Keywords:  Gompertz model; Rhabdomyosarcoma; fractional calculus; tumour growth

Mesh:

Year:  2014        PMID: 24468637     DOI: 10.1093/imammb/dqt024

Source DB:  PubMed          Journal:  Math Med Biol        ISSN: 1477-8599            Impact factor:   1.854


  2 in total

Review 1.  Diffusion through skin in the light of a fractional derivative approach: progress and challenges.

Authors:  Michele Caputo; Cesare Cametti
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-09-04       Impact factor: 2.745

2.  Timescale of tumor volume of a young breast cancer patient with luminal B subtype: A case report.

Authors:  Xiaoyun Mao; Ming Zhou; Chuifeng Fan; Bo Chen; Feng Jin
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.